Published in J Heart Lung Transplant on September 15, 2005
HeartWare and HeartMate II left ventricular assist devices as bridge to transplantation: a comparative analysis. Ann Thorac Surg (2013) 1.41
Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization. J Heart Lung Transplant (2009) 1.37
Report from a consensus conference on the sensitized patient awaiting heart transplantation. J Heart Lung Transplant (2009) 0.97
Management of allosensitized cardiac transplant candidates. Transplant Rev (Orlando) (2009) 0.93
Effect of sensitization in US heart transplant recipients bridged with a ventricular assist device: update in a modern cohort. J Thorac Cardiovasc Surg (2011) 0.89
Heart failure in patients with human immunodeficiency virus infection: epidemiology, pathophysiology, treatment, and future research. Circulation (2014) 0.87
Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization. Blood (2007) 0.83
Ventricular assist devices: pharmacological aspects of a mechanical therapy. Pharmacol Ther (2012) 0.80
LVAD implant as a bridge to heart transplantation is associated with allosensitization as measured by single antigen bead assay. Transplantation (2013) 0.79
Thymoglobulin induction in heart transplantation: patient selection and implications for maintenance immunosuppression. Transpl Int (2014) 0.76
Occurrence of Fatal and Nonfatal Adverse Outcomes after Heart Transplantation in Patients with Pretransplant Noncytotoxic HLA Antibodies. J Transplant (2013) 0.76
Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J (2004) 3.70
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation (2004) 3.29
Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: single-institution experience in 358 consecutive patients. Ann Thorac Surg (2007) 3.21
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant (2013) 2.71
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support. Circulation (2009) 2.70
Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J (2008) 2.63
Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med (2012) 2.62
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group. Circulation (2007) 2.34
Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging (2009) 2.34
Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures. Circulation (2007) 2.25
Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis. Am J Respir Crit Care Med (2014) 2.13
Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension. Am J Respir Crit Care Med (2010) 2.09
Molecular remodelling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy. Lancet (2002) 2.06
Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circ Res (2012) 2.02
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA (2007) 1.91
Left ventricular untwisting rate by speckle tracking echocardiography. Circulation (2007) 1.74
Surgical outcome in 85 patients with primary cardiac tumors. Am J Surg (2003) 1.72
Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol (2006) 1.68
Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-Noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant (2005) 1.64
Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability. Clin Transl Sci (2008) 1.53
The feasibility of lung transplantation in HIV-seropositive patients. Ann Am Thorac Soc (2014) 1.41
Initial clinical experience of total cardiac replacement with dual HeartMate-II axial flow pumps for severe biventricular heart failure. Methodist Debakey Cardiovasc J (2011) 1.37
Placement of a left ventricular assist device in a patient with dextrocardia. J Heart Lung Transplant (2005) 1.19
Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices. J Am Coll Cardiol (2004) 1.17
Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy. Circulation (2013) 1.16
Degree of cardiac fibrosis and hypertrophy at time of implantation predicts myocardial improvement during left ventricular assist device support. J Heart Lung Transplant (2004) 1.12
Skeletal muscle BOLD MRI: from underlying physiological concepts to its usefulness in clinical conditions. J Magn Reson Imaging (2012) 1.10
Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation. Kidney Int (2012) 1.09
Contrast-enhanced ultrasound for assessing carotid atherosclerotic plaque lesions. AJR Am J Roentgenol (2012) 1.09
Experience with over 1000 implanted ventricular assist devices. J Card Surg (2008) 1.07
Impact of body mass index on outcome in patients after coronary artery bypass grafting with and without valve surgery. Eur Heart J (2003) 1.07
Current status of the MicroMed DeBakey Noon Ventricular Assist Device. Tex Heart Inst J (2010) 1.05
Characteristics of T-cell receptor repertoire and myelin-reactive T cells reconstituted from autologous haematopoietic stem-cell grafts in multiple sclerosis. Brain (2004) 1.03
Early mobilization of LVAD recipients who require prolonged mechanical ventilation. Tex Heart Inst J (2006) 1.02
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS). Am Heart J (2005) 1.01
Comparison of hemodynamics in the ascending aorta between pulsatile and continuous flow left ventricular assist devices using computational fluid dynamics based on computed tomography images. Artif Organs (2013) 1.01
Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection. Transplantation (2014) 0.99
Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J Card Fail (2010) 0.98
Strategy for rapid identification and antibiotic susceptibility testing of gram-negative bacteria directly recovered from positive blood cultures using the Bruker MALDI Biotyper and the BD Phoenix system. J Clin Microbiol (2012) 0.97
Influence of LVAD cannula outflow tract location on hemodynamics in the ascending aorta: a patient-specific computational fluid dynamics approach. ASAIO J (2012) 0.97
Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol (2003) 0.95
Revascularization and ventricular restoration in patients with ischemic heart failure: the STICH trial. Curr Opin Cardiol (2003) 0.95
Evidence of improved right ventricular structure after LVAD support in patients with end-stage cardiomyopathy. J Heart Lung Transplant (2004) 0.93
Outpatients on mechanical circulatory support. Ann Thorac Surg (2003) 0.93
Cytokines and acute heart failure. Crit Care Med (2008) 0.93
Myocardial recovery in peripartum cardiomyopathy: prospective comparison with recent onset cardiomyopathy in men and nonperipartum women. J Card Fail (2011) 0.92
Atherosclerosis and inflammation. Curr Atheroscler Rep (2002) 0.92
Decorin-mediated transforming growth factor-beta inhibition ameliorates adverse cardiac remodeling. J Heart Lung Transplant (2006) 0.92
Dobutamine stress echocardiography predicts myocardial improvement in patients supported by left ventricular assist devices (LVADs): hemodynamic and histologic evidence of improvement before LVAD explantation. J Heart Lung Transplant (2003) 0.92
Coronary pseudoaneurysm: an unreported complication of Castleman's disease. Ann Thorac Surg (2006) 0.91
Hypoxia-induced deoxycytidine kinase expression contributes to apoptosis in chronic lung disease. FASEB J (2013) 0.88
Blood oxygenation level-dependent (BOLD) MRI of human skeletal muscle at 1.5 and 3 T. J Magn Reson Imaging (2012) 0.88
Immunoglobulin therapy for plasma cell-rich rejection in the renal allograft. Transplantation (2006) 0.88
Longitudinal computational fluid dynamics study of aneurysmal dilatation in a chronic DeBakey type III aortic dissection. J Vasc Surg (2012) 0.88
Reversal of pulmonary hypertension and subsequent repair of atrial septal defect after treatment with continuous intravenous epoprostenol. J Heart Lung Transplant (2005) 0.87
Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support. J Heart Lung Transplant (2009) 0.87
Contrast-enhanced Duplex surveillance after endovascular abdominal aortic aneurysm repair: improved efficacy using a continuous infusion technique. J Vasc Surg (2006) 0.87
Organ-specific regulation of pro-inflammatory molecules in heart, lung, and kidney following brain death. J Surg Res (2005) 0.87
Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. J Card Fail (2012) 0.87
The role of mast cells after solid organ transplantation. Transplantation (2008) 0.87
Application of stereolithography for scaffold fabrication for tissue engineered heart valves. ASAIO J (2002) 0.86
Imaging for ventricular function and myocardial recovery on nonpulsatile ventricular assist devices. Circulation (2012) 0.86
Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol (2008) 0.86
Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients. J Surg Res (2005) 0.86
The MicroMed DeBakey VAD--part I: The pump and the blood flow. J Extra Corpor Technol (2003) 0.86
Acoustic analysis of a mechanical circulatory support. Artif Organs (2013) 0.85
TandemHeart insertion via a femoral arterial GORE-TEX graft conduit in a high-risk patient. Tex Heart Inst J (2008) 0.85
Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures. J Cardiothorac Surg (2014) 0.85
The hemodynamic and neurohormonal effects of low doses of tezosentan (an endothelin A/B receptor antagonist) in patients with acute heart failure. Eur J Heart Fail (2004) 0.84
Adenosine A2B receptor and hyaluronan modulate pulmonary hypertension associated with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2013) 0.84
Worsening heart failure, a critical event during hospital admission for acute heart failure: results from the VERITAS study. Eur J Heart Fail (2014) 0.84
Mast cell-derived cathepsin g: a possible role in the adverse remodeling of the failing human heart. J Surg Res (2007) 0.84
Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure. J Heart Lung Transplant (2008) 0.84
A case series of reversible acute cardiomyopathy associated with H1N1 influenza infection. Methodist Debakey Cardiovasc J (2012) 0.84
Patients supported for over 4 years with left ventricular assist devices. Eur J Heart Fail (2006) 0.84